Table 6.
Patient Groups | lDl-C Target | hDl-C Target | Triglyceride Target |
---|---|---|---|
Individuals with no clinical ASCVD | <130 mg/dL | >40 mg/dl in males / >50 mg/dl in females | <150 mg/dl |
Individuals with DM | <100 mg/dL | >40 mg/dl in males / >50 mg/dl in females | <150 mg/dl |
With ≥1 risk factors / target organ damage | <70 mg/dL | ||
With ASCVD | <55 mg/dL | ||
Individuals with clinical ASCVD | <55 mg/dL | 40 mg/dl in males / >50 mg/dl in females > | <150 mg/dl |
FH without ASCVD or without major risk factor / target organ damage | <70 mg/dL | 40 mg/dl in males / >50 mg/dl in females > | <150 mg/dl |
FH with ASCVD or with ≥1 risk factors / target organ damage | <55 mg/dL |
ASCVD, atherosclerotic cardiovascular disease; DM, diabetes mellitus; FH, familial hypercholesterolemia